Biomarker Discovery Outsourcing Services Market Set to Reach $31.22 Billion by 2029 with 16.4% Yearly Growth

What combination of drivers is leading to accelerated growth in the biomarker discovery outsourcing services market?
As personalized medicine garners more attention, the biomarker discovery outsourcing services market is predicted to grow. Personalized medicine is an approach to patient care that takes into account individual patient characteristics to customize treatment plans. The shift towards personalized medicine is influenced by factors such as genetic traits, environmental conditions, and lifestyle habits, which culminate in precision medicine outcomes. These outcomes not only enhance patient care but also minimize negative effects. Outsourcing services for biomarker discovery contribute to the progression of personalized medicine by offering diagnostic and therapeutic strategies based on a patient's unique biological markers. In 2023, the FDA approved 16 new personalized treatments for uncommon diseases, reflecting a substantial increase from the six approved treatments in 2022, as per a report by the Personalized Medicine Coalition, a US-based group. The treatments given the green light in 2023 encompassed seven cancer drugs and three aimed at other diseases or conditions. Thus, the expanding emphasis on personalized medicine fuels the growth of the biomarker discovery outsourcing services market.

Get Your Biomarker Discovery Outsourcing Services Market Report Here:
https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

What is the projected compound annual growth rate (CAGR) of the biomarker discovery outsourcing services market from 2025 to 2034, and what factors influence it?
The market size of biomarker discovery outsourcing services has seen a substantial expansion in the past few years. It is anticipated to surge from $14.58 billion in 2024 to $17.01 billion in 2025, boasting a compound annual growth rate (CAGR) of 16.7%. Factors contributing to this significant growth during the historic period include a rising disease burden, an increased demand for pharmaceutical R&D, changes in the regulatory landscape, more cost-effective options, partnerships in research and the effects of globalization.

The market size for biomarker discovery outsourcing services is projected to experience substantial growth in the upcoming years, escalating to $31.22 billion in 2029 with a compound annual growth rate (CAGR) of 16.4%. Factors contributing to the growth during the forecast period involve the expansion of personalized medicine, incorporation of AI and machine learning, rise in precision oncology, services related to biomarker validation, regulatory backing, demand for targeted therapy, and a shift towards patient-oriented healthcare. The forecast period will also see major trends such as a surge in precision medicine adoption, technology advancements, increasing requirement for companion diagnostics, broadening drug development pipelines, breakthrough applications in non-traditional disease sectors, AI and machine learning integration, regulatory advocacy and standardization, global market growth, partnerships and alliances, and an emphasis on cost efficiencies and time management.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15741&type=smp

How are the latest trends influencing the growth of the biomarker discovery outsourcing services market?
Key businesses in the biomarker discovery outsourcing services market are concentrating their efforts on creating multiplexed biomarker assays, such as the immunoproteomic discovery platform, in order to enhance patient results and progress the biomarker discovery field. The immunoproteomic discovery platform is a unique system that merges immunology and proteomics to detect and scrutinize proteins involved in the immune response. Take for instance, in October 2023, Sengenics Corporation LLC, a firm specializing in precision medicine based in Singapore, introduced the immunoproteomic discovery platform, a wide-ranging protein microarray platform for the examination of autoantibodies linked with disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was conceived to propel immune biomarker discovery and development, while also aiding academic and clinical biopharmaceutical research groups aiming to deepen their understanding of the complex interactions and linkages between proteins, the immune system, and diseases.

What are the major segments of the biomarker discovery outsourcing services market and their role in driving growth?
The biomarker discovery outsourcing services market covered in this report is segmented -

1) By Type: Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints
2) By Discovery Phase: Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection
3) By Therapeutic Area: Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas
4) By End Use: Pharmaceutical Companies, Biotechnology Companies

Subsegments:
1) By Predictive Biomarkers: Disease Risk Assessment, Therapy Response Prediction, Personalized Medicine Guidance
2) By Prognostic Biomarkers: Disease Progression Prediction, Patient Survival Forecast, Recurrence Risk Assessment
3) By Safety Biomarkers: Toxicity Prediction, Drug Safety Evaluation, Adverse Effect Risk Assessment
4) By Surrogate Endpoints: Clinical Trial Outcome Indicators, Disease Progression Monitoring, Therapy Efficacy Tracking

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15741

Which regions are key players in the growth of the biomarker discovery outsourcing services market?
North America was the largest region in the biomarker discovery outsourcing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the key firms paving the way for growth in the biomarker discovery outsourcing services market?
Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15741&type=smp

What Is Covered In The Biomarker Discovery Outsourcing Services Global Market Report?

•Market Size Forecast: Examine the biomarker discovery outsourcing services market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the biomarker discovery outsourcing services market for a structured understanding.
•Key Players Overview: Analyze major players in the biomarker discovery outsourcing services market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the biomarker discovery outsourcing services market.
•Segment Contributions: Evaluate how different segments drive overall growth in the biomarker discovery outsourcing services market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the biomarker discovery outsourcing services market.
•Industry Challenges: Identify potential risks and obstacles affecting the biomarker discovery outsourcing services market.
•Competitive Landscape: Review strategic developments in the biomarker discovery outsourcing services market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.